Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

HISTORICAL FACTS: 54 - The Untold Story

13 inflation-proof stocks to buy for 2024

These companies are poised to ride the AI boom and protect investors from the impact of higher interest rates.

Fortune

Tech firm Palantir rejects concerns over role in NHS data platform plans

US tech giant Palantir has rejected concerns after the firm was awarded a contract worth hundreds of millions of pounds for a new NHS data platform.

The Independent UK

Peter Thiel-cofounded Palantir will overhaul the U.K.’s public health service in a deal worth up to $413m—and people are worried

Palantir previously worked with the NHS during COVID-19, helping with vaccine rollout for a grand sum of £1. But people remain skeptical about the deal.

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

MPs to press new Health Secretary on NHS data platform plans

The health and social care committee said the Government has acknowledged it ‘needed to do better to communicate the benefits of digital healthcare’.

The Independent UK

Palantir’s Peter Thiel: NHS is a natural target for outspoken tech billionaire

Silicon Valley outsider whose firm has won data contract has previously said health service should be ripped up to ‘start over’

The Guardian - UK

Patient privacy fears as US spy tech firm Palantir wins £330m NHS contract

Awarding of contract to create new data platform prompts immediate concerns about security of medical records

The Guardian - UK

TechScape: Are social media giants silencing online content?

As violence on the ground continues, emotions on social media are higher than ever – with critics asking if platforms need more transparency around their algorithms

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

NHS England gives contract to handle patient data to US spy tech firm

NHS England is set to hand over a key role in handling patient data to a US spy technology firm.

The National (Scotland)

NHS England gives key role in handling patient data to US spy tech firm Palantir

Exclusive: Company that works with intelligence services wins £480m contract in joint bid with Accenture

The Guardian - UK

Is It Too Late to Buy Palantir Stock?

Palantir stock has more than tripled in 2023, delivering outsized gains for shareholders. But it now trades at a premium valuation, and may pull back in the near term.

Barchart

Patients may shun new NHS data store over privacy fears, doctors warn

BMA raises concerns with minister about planned data platform, which could be run by US firm Palantir

The Guardian - UK

Palantir's Free Cash Flow Surges, Pushing PLTR Stock and Its Target Price Higher

Palantir Technologies reported strong revenue growth and a huge rise in its free cash flow and FCF margins. This helps raise analysts' target prices and increases the underlying value of PLTR stock.

Barchart

Stock Market Today: Dow Jumps 564 Points Ahead of October Jobs Report

The main indexes carved out a fourth straight win Thursday on hope the Fed is done raising interest rates.

Kiplinger

Virgin Galactic astronaut Kellie Gerardi is ready for broader access to space

Just days before her first spaceflight, Kellie Gerardi talks about the importance of microgravity research and making the final frontier more accessible for all.

Space

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Up 155% in 2023, Why Is Wall Street So Bearish on Palantir Stock?

PLTR shares have skyrocketed this year, driven by the software company's AI ambitions. Here's a closer look at Wall Street's deeply split opinions on this outperforming growth stock, and what might be next for Palantir.

Barchart

3 Software Stocks Analysts Like Better Than Palantir

Palantir has had a remarkable rally so far in 2023. However, there are three other software stocks that analysts believe have more upside from current levels.

The Guardian - UK

Half a million of us want to donate our data to British science, but it’s languishing unused because of privacy fears

Data supplied to UK Biobank UK is not for sale, it’s not for trivial or suspect use, it’s for the good of humankind, says Guardian columnist Polly Toynbee

The Guardian - UK

Everything you need to know about NHS England’s biggest ever IT contract

What is the contract for? And why are there privacy concerns about the deal?

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Palantir Stock: An Underrated AI Growth Pick

Palantir just won over two big clients, but shares of the AI innovator still seem stuck. Is this an opportunity to scoop up the overlooked AI stock?

Barchart

Mild, Medium & Hot: 3 Unusually Active Option Plays for Thursday

The markets are bouncing between positive and negative territory early in September's penultimate trading day. Barring a massive move today or Friday, the S&P 500 will finish the month significantly lower than it started.

The Independent UK

Horseracing Integrity and Safety Authority says progress is being made in the sport

Industry leaders are defending and praising the work of the Horseracing Safety and Integrity Authority in the aftermath of a competing piece of legislation being introduced in the U.S. House of Representatives

Zenger

Palantir CEO Urges Tech Companies To Collaborate With Government On AI Initiatives

Alex Karp emphasizes the need for cooperation to mitigate risks and maintain global competitiveness.

StockNews.com

3 Software Stocks to Watch for Potential Breakout Growth This Week

With organizations embracing innovative software solutions across diverse business functions globally, the software industry is poised for sustained and steady growth. Hence, fundamentally sound software stocks Palantir Technologies (PLTR), Elastic (ESTC), and Smartsheet (SMAR), with massive growth potential, might be ideal additions to one’s watchlist. Read more.

Barchart

3 AI Stocks to Avoid at Current Prices

Despite a sharp pullback from their mid-summer highs, all three of these stocks from the artificial intelligence (AI) industry still look expensive at current levels, and are best avoided by investors.

The Guardian - UK

‘Our health data is about to flow more freely, like it or not’: big tech’s plans for the NHS

The long read: The government is about to award a £480m contract to build a vast new database of patient data. But if people don’t trust it, they’ll opt out – I know, because I felt I had to

1 … 53 54 55 56

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations